|
COVID-19 Reinfection & Second Infection
|
4 |
0 |
0 |
|
Autoimmune & Diseases And COVID-19
|
6 |
0 |
0 |
|
Buvo & Nuo
|
6 |
0 |
0 |
|
Des & Les
|
10 |
0 |
0 |
|
ABO Blood Group
|
18 |
0 |
0 |
|
Hogy & Betegek
|
23 |
0 |
0 |
|
Die & Mit
|
26 |
0 |
0 |
|
IBD Patients & Inflammatory Bowel Disease (IBD)
|
26 |
0 |
0 |
|
Wearing & Face Mask Use
|
26 |
0 |
0 |
|
Coronavirus Infection & Данных GISAID За
|
40 |
0 |
0 |
|
Breakthrough Infections & Fully Vaccinated
|
43 |
0 |
1 |
|
Oraz & 25(OH)
|
46 |
0 |
0 |
|
Food Security & Food Insecurity
|
47 |
0 |
1 |
|
Bir & Ile
|
50 |
0 |
0 |
|
Residents & Nursing Homes
|
55 |
0 |
0 |
|
SARS-CoV-2 RNA & Genome
|
57 |
0 |
1 |
|
Liver Injury & AKI
|
61 |
0 |
0 |
|
Wastewater Surveillance & Samples
|
61 |
0 |
1 |
|
RSV & Respiratory Viruses
|
66 |
0 |
0 |
|
Tuberculosis & HIV And SARS-CoV
|
71 |
0 |
0 |
|
Grant/Research Support & Advisor/Consultant
|
80 |
0 |
0 |
|
Dental & Oral
|
81 |
0 |
0 |
|
Long COVID-19 & Long COVID Symptoms
|
88 |
0 |
4 |
|
Post-COVID-19 & COVID-19 Syndrome
|
92 |
0 |
3 |
|
Placebo-controlled & Randomized
|
94 |
0 |
6 |
|
Type Diabetes Mellitus & Mucormycosis
|
95 |
0 |
2 |
|
Dengan & Pada
|
96 |
0 |
0 |
|
COVID-19 Vaccine & Hesitancy, Acceptance
|
100 |
0 |
4 |
|
Images & Deep Learning
|
100 |
0 |
0 |
|
Variants & SARS-CoV-2 Omicron
|
111 |
0 |
13 |
|
Systematic Review And Meta & Review And Meta-analysis
|
112 |
0 |
1 |
|
Antibiotic & Bacterial Infections
|
118 |
0 |
0 |
|
COVID-19 Pneumonia & Lung
|
127 |
0 |
1 |
|
COVID-19 Lockdown & Air Quality
|
131 |
0 |
0 |
|
COVID-19 Vaccination & MRNA
|
137 |
0 |
4 |
|
Healthcare Workers & Nurses
|
150 |
0 |
0 |
|
Pandemi Covid-19 & Penelitian
|
161 |
0 |
0 |
|
Inflammatory & Mice
|
165 |
0 |
5 |
|
Pregnant Women & Pregnancy And Improves Maternal
|
189 |
0 |
3 |
|
MIS & Children And Adolescents
|
218 |
0 |
3 |
|
Older Adults & Services
|
218 |
0 |
1 |
|
Del & Por Una
|
226 |
0 |
0 |
|
Surgery & Cancer Patients
|
236 |
0 |
0 |
|
Social Media & Public Health
|
240 |
0 |
1 |
|
COVID-19 Patients & Genes
|
254 |
0 |
0 |
|
Testing & Detection
|
257 |
0 |
2 |
|
Tourism & Financial
|
271 |
0 |
0 |
|
Transmission Model & Outbreak
|
291 |
0 |
2 |
|
Mental Health & Depression, Anxiety
|
294 |
0 |
6 |
|
Antiviral & Protease
|
305 |
0 |
2 |
|
IgG Antibody & Booster
|
314 |
0 |
17 |
|
Students & Online Learning
|
318 |
0 |
0 |
|
Com & Para Uma
|
320 |
0 |
0 |
|
COVID-19 Infection & Neurological
|
325 |
0 |
3 |
|
Omicron And Delta & SARS-CoV-2 Variants
|
352 |
0 |
7 |
|
Protein (iACE2 & Binding Domain (RBD)
|
361 |
0 |
10 |
|
Cell & Vaccines
|
437 |
0 |
10 |
|
Mortality And ICU & Wave
|
540 |
0 |
8 |
